Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Observations on antibody reaction scores on individual patients.
D000917:Antibody Formation / Q000187:drug effects; D000937:Antigen-Antibody Reactions / Q000187:drug effects*; D003864:Depression, Chemical; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D013997:Time Factors
D012293:Rifampin